Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer
Ricardo Coelho(University of Basel), Viola Heinzelmann‐Schwarz(Roche (Switzerland))
Cited by 24
Related Papers
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Low meprin α expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries
|Journal of Clinical Pathology|2006|25
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
|Nature Communications|2024|25
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
|International Journal of Oncology|2022|9